Ugandan scientists have developed a drug from natural herbs that can cure malaria in about three days.
According to a study released by the scientists, the drug, DEI Anti-malaria, can eliminate malaria-causing parasites within the human body using natural compounds extracted from plants.
Laboratory Testing and Findings
The lead investigator, Dr. Patrick Ogwang, a pharmacist and lecturer at Mbarara University of Science and Technology, confirmed that laboratory tests have proven the drug to be both safe and efficacious.
“Parasites were obtained from malaria patients in Mulago Hospital and subjected to the drug in the laboratory. They were all killed by the compounds of the drug,” said Dr. Ogwang.
He further explained:
“It was also tested on mice and successfully eliminated all parasites without causing toxicity to body organs such as the liver, kidney, and bone marrow.”
Need for an African Solution
Despite modern medicines playing a crucial role in containing malaria, Dr. Ogwang emphasized their high cost and vulnerability to parasite resistance. He highlighted the necessity for a cost-effective African solution.
The natural traditional medicinal formula has reportedly been in use for over 40 years, effectively treating various forms of malaria, including the Plasmodium falciparum-resistant variant.
Regulatory Progress and Formulation
Findings from laboratory tests have been submitted to the National Drug Authority (NDA) and have been assigned a notification number THA218.
The drug’s prototype is currently available in the following formulations:
- Capsules – For adults
- Powdered substance – To be taken as a syrup by children
DEI Group’s Vision for Malaria Treatment
Dr. Mathias Magoola, the Managing Director of DEI Group of Companies, who owns the drug formula, emphasized its potential to combat malaria, a disease responsible for nearly 50% of illnesses across Africa.
Speaking at the launch of the study findings in Kampala, Dr. Elioda Tumwesigye, the then Minister of Science and Innovation, pledged his support to the scientists in securing patents and further developing the herbal drug.
“The drug still needs to go through all stages of drug development before it is approved for mass production and use,” Dr. Tumwesigye stated.
Approval Process by the NDA
Ms. Florence Nakacwa, Head of Drug Assessment at NDA, noted that the drug is yet to receive full approval.
She explained:
“For a drug to be approved, it must meet labeling requirements, complete all clinical trials, and its production facility must be inspected and accredited by NDA.”
